NLRP3抑制剂:释放它们对抗炎症疾病的治疗潜力
1Department of Natural Products and Medicinal Chemistry, CSIR-Indian Institute of Chemical Technology, Hyderabad 500007, India; Academy of Scientific and Innovative Research (AcSIR), Ghaziabad 201002, India.
Biochemical pharmacology
|November 10, 2023
概括
类似NOD的受体pyrin域含有蛋白3 (NLRP3) 炎症体驱动炎症,但其抑制剂会引起副作用. 本综述探讨了NLRP3炎症酶通路和临床开发的治疗策略.
科学领域:
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 类似NOD的受体pyrin域含有蛋白3 (NLRP3) 炎症体对天生的免疫非常重要,它调解了对感染和危险信号的炎症反应.
- NLRP3炎症酶激活导致促炎细胞因子的释放,加剧组织损伤和炎症.
研究的目的:
- 审查NLRP3炎症酶复合体组装,原始化和激活的过程.
- 讨论目前NLRP3炎症酶的治疗抑制剂.
- 探索推进NLRP3炎酶向疗法进入临床开发的潜在策略.
主要方法:
- 文献综述侧重于NLRP3炎症酶通路.
- 对现有的治疗NLRP3炎症酶抑制剂的分析.
- 讨论临床翻译方面的挑战和机遇.
主要成果:
- NLRP3炎症酶抑制剂显示出显著的抗炎作用,但与严重的副作用有关.
- 许多开发的NLRP3抑制剂在临床试验中面临挑战并失败.
- 了解NLRP3炎症酶调节是开发有效治疗的关键.
结论:
- 尽管存在挑战,但NLRP3炎症酶抑制剂为炎症性疾病提供了可行的治疗选择.
- 需要对NLRP3炎症酶机制和向抑制进行进一步的研究.
- 开发安全有效的NLRP3炎酶向药物需要仔细考虑临床策略.
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
147
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
147
NF-κB-dependent Signaling Pathway
7.5K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.5K
Inflammatory Bowel Disease IV: Pharmacological Management
134
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
134
Inflammatory Response
2.1K
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
2.1K
Nociception
27.9K
Nociception—the ability to feel pain—is essential for an organism’s survival and overall well-being. Noxious stimuli such as piercing pain from a sharp object, heat from an open flame, or contact with corrosive chemicals are first detected by sensory receptors, called nociceptors, located on nerve endings. Nociceptors express ion channels that convert noxious stimuli into electrical signals. When these signals reach the brain via sensory neurons, they are perceived as pain.
27.9K


